Key clinical point: 3D template mapping detects more prostate cancer than conventional free-hand sampling.
Major finding: Template biopsy detected prostate cancer in 257/530 men and clinically-significant cancer in 196/530 men, whereas conventional biopsy detected cancer in 432/1052 men and clinically-significant cancer in 308/1,052 men.
Study details: The study included 1,052 patients who underwent conventional biopsy and 530 who underwent template biopsy with an MRI/Ultrasound fusion device.
Zhou SR, et al. J Urol. 2019 Oct 9:101097JU0000000000000587. doi: 10.1097/JU.0000000000000587.